Current pharmacotherapy of overactive bladder
Int. braz. j. urol
;
47(6): 1091-1107, Nov.-Dec. 2021. tab
Artículo
en Inglés
| LILACS
| ID: biblio-1340029
ABSTRACT
ABSTRACT Overactive bladder is a symptom complex consisting of bothersome storage urinary symptoms that is highly prevalent among both sexes and has a significant impact on quality of life. Various antimuscarinic agents and the beta-3 agonists mirabegron and vibegron are currently available for the treatment of OAB. Each drug has specific pharmacologic properties, dosing schedule and tolerability profile, making it essential to individualize the medical treatment for the patient's characteristics and expectations. In this manuscript, we review the most important factors involved in the contemporary pharmacological treatment of OAB.
Texto completo:
Disponible
Índice:
LILACS (Américas)
Asunto principal:
Vejiga Urinaria Hiperactiva
Límite:
Femenino
/
Humanos
/
Masculino
Idioma:
Inglés
Revista:
Int. braz. j. urol
Asunto de la revista:
Urología
Año:
2021
Tipo del documento:
Artículo
País de afiliación:
Brasil
/
Portugal
/
Estados Unidos
Institución/País de afiliación:
Faculdade de Medicina da Universidade de São Paulo/BR
/
Faculdade de Medicina do Porto/PT
/
University of Southern California/US
Similares
MEDLINE
...
LILACS
LIS